briefingcom
$MYL: Mylan Labs comments on unfavorable Copaxone ruling; says 'we fully intend to evaluate our options for an... http://t.co/rHYjhVEw
- About
- Help
- Blog
- Jobs
- Press
- Tools
- Mobile
- Developers
- House Rules
- For Public Companies
- For Market Professionals
-
- Terms
- Privacy
- Disclaimer
- Market Quotes provided by Xignite © 2013 StockTwits, Inc.